Antigenics Inc.

Antigenics Inc.
Search
Products and TechnologiesClinical TrialsNewsroomInvestorsJobsAbout Antigenics

Investigational products for infectious disease

AG-707
Off-the-shelf immunotherapeutic being developed to treat genital herpes infection

QS-21
Immune adjuvant designed to ‘boost’ immune response to vaccine antigens

Quilimmune-P
QS-21–containing vaccine for pneumococcal infection

Antigenics home pageSitemap for antigenics.comGlossaryContact Antigenics